Operating Grant: Innovative Biomedical and Clinical HIV/AIDS Research
The Operating Grant: Innovative Biomedical and Clinical HIV/AIDS Research will support innovative or high-risk biomedical and clinical research directly relevant to the priority objectives of the CIHR HIV/AIDS Research Initiative.
The specific objectives of the funding opportunity are to:
- Enable new and established investigators to undertake innovative research projects in new areas of investigation or take previous discoveries in new directions;
- Promote the development and testing of novel research tools and methodologies); and
- Support high-risk research projects with the potential for high impact, breakthrough and/or transformative advances.
Relevant Research Areas
- Biology of early HIV infection, pathogenesis and immunology relevant to the identification of new immunogens, correlates of protection and other aspects of HIV prevention.
- Host and viral factors influencing HIV persistence (including viral latency) and viral reservoirs; creating models (cellular and animal) of HIV latency and assays to measure persistent HIV infection; and other aspects of HIV cure strategies.
- Approaches to vaccine development including novel adjuvants and platforms for immunization.
- Virological and biological aspects of aging and co-morbid conditions (e.g., chronic diseases and co-infections) for people living with HIV.
